Health Services Corporation of America has extended its purchasing agreement contract with Amersham until April 30, 2006. HSCA members will continue to have access to the company’s x-ray and MRI contrast media products, as well as their
Health Services Corporation of America has extended its purchasing agreement contract with Amersham until April 30, 2006. HSCA members will continue to have access to the company’s x-ray and MRI contrast media products, as well as their brachytherapy products. Members include healthcare organizations that participate in HSCA’s Select Radiology Block. Launched in May 2000, the program was designed to reward compliance for hospitals and health systems, and to drive market share to participating suppliers.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.